Skip to search formSkip to main contentSkip to account menu

Epidermal growth factor receptor (EGFR) signaling in cancer.

View on PubMed (opens in a new tab)

Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo.

TLDR
It is reported, for the first time to the authors' knowledge, that Cripto can directly bind to another TGF-beta ligand, Activin B, and thatCripto overexpression blocks ActivinB growth inhibition of breast cancer cells, suggesting a novel mechanism for antagonizing Activin signaling that could promote tumorigenesis by deregulating growth homeostasis.
View on PubMed (opens in a new tab)

Cripto-1 Activates Nodal- and ALK4-Dependent and -Independent Signaling Pathways in Mammary Epithelial Cells

TLDR
CR-1 binds to cell surface ALK4 expressed on mammalian epithelial cells in fluorescence-activated cell sorter analysis, as well as by coimmunoprecipitation, suggesting that CR-1 may modulate different signaling pathways to mediate its different functional roles.
View on ASMUSA (opens in a new tab)

Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis

TLDR
The role of Cripto-1 during embryogenesis, cell migration, invasion and angiogenesis and how these activities may relate to cellular transformation and tumorigenesis are reviewed.
View on Springer (opens in a new tab)

Target-based agents against ErbB receptors and their ligands: a novel approach to cancer treatment.

TLDR
The mechanisms of action of these compounds, as well as the potential therapeutic strategies to improve their efficacy are discussed in this review with particular regard to the combinations of anti-ErbB agents with cytotoxic drugs, or combinations of different ErbB-targeting agents.
View on PubMed (opens in a new tab)

Epithelial mesenchymal transition is a characteristic of hyperplasias and tumors in mammary gland from MMTV‐Cripto‐1 transgenic mice

TLDR
The expression of molecular markers and signaling molecules characteristic of EMT were assessed in mammary gland hyperplasias and tumors from mice expressing the human CR‐1 transgene by the MMTV promoter (MMTV‐CR‐1) and in mouse mammary epithelial cell line HC‐11 overexpressing CR‐2.
View on Wiley (opens in a new tab)

Role of Cripto-1 during epithelial-to-mesenchymal transition in development and cancer.

View on PubMed (opens in a new tab)

The role of EGF-related peptides in tumor growth.

TLDR
Data strongly suggest that the EGF-like peptides are involved in the pathogenesis of human carcinomas, and that they might represent suitable targets for novel therapeutic approaches.
View on PubMed (opens in a new tab)

Requirement of Glycosylphosphatidylinositol Anchor of Cripto-1 for trans Activity as a Nodal Co-receptor*

TLDR
GPI attachment of CR-1 is required for the paracrine activity as a Nodal co-receptor in trans as well as in cis, and COOH-terminal-truncated soluble forms ofCR-1 are generated based on the attachment site for the GPI moiety.
View on Publisher (opens in a new tab)

A Nodal- and ALK4-independent signaling pathway activated by Cripto-1 through Glypican-1 and c-Src.

TLDR
It is demonstrated that CR-1 specifically binds to Glypican-1, a membrane-associated heparan sulfate proteoglycan, and activates the tyrosine kinase c-Src, triggering the mitogen-activated protein kinase and Akt signaling pathways.
View on PubMed (opens in a new tab)
...
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)